Search

everythinglearnresearchcommunity

for

Search:↓

Eclipta alba extract shows potential as an anticancer agent by inhibiting cancer cell growth and promoting cell death.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

The Korean study confirmed that bariatric surgery is effective for weight loss in Asians.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.